<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=780280282443813&amp;ev=PageView&amp;noscript=1">
search

    OpGen, Inc.

    verified_userVerify Profile
    Companies » Health Care » Health Care Equipment & Services » Biotechnology

    About OpGen, Inc.

    OpGen, Inc. is a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease. We are developing molecular information products and services for global healthcare settings, helping to guide clinicians with more rapid and actionable information about life threatening infections, improve patient outcomes, and decrease the spread of infections caused by multidrug-resistant microorganisms, or MDROs. Source

    At A Glance

    • CAPITAL RAISE STATUS
      Not Currently Raising
    • FILING TYPE
      Public
    • PLATFORM TYPE
      NASDAQ
    • RAISED AMOUNT
      $X,XXX,XXX
    • PRE-MONEY EVAULATION
      $X,XXX,XXX
    • SIC CODE
      8071
    • NIN CODE
      ####
    • LEADERSHIP
      Evan Jones
    • FOUNDED
      2002
    • EMPLOYEES
      20
    • SECTOR
      Health Care Equipment & Services
    • SUBSECTOR
      Biotechnology

    Company Tags

    No articles found.

    Kerluxe, Inc.

    Kerluxe, Inc.

    The Kerluxe brand philosophy is to employ innovation synonymous with Swiss skincar...

    The Kerluxe brand philosophy is to employ innov...

    Fundraising Status:    EC
    Filing Type:    RA
    Viking Therapeutics, Inc.

    Viking Therapeutics, Inc.

    Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the d...

    Viking Therapeutics is a clinical-stage biophar...

    Filing Type:    PU
    Medivie USA Inc

    Medivie USA Inc

    Medivie Therapeutic is an Israeli public company, which developed Laboraide – a ...

    Medivie Therapeutic is an Israeli public compan...

    Filing Type:    RA
    Cytonics Corp

    Cytonics Corp

    Cytonics, founded in 2006, is a private research and development company focused o...

    Cytonics, founded in 2006, is a private researc...

    Amount Raised:    $3,300,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Harvard Bioscience, Inc.

    Harvard Bioscience, Inc.

    Harvard Bioscience is a global developer, manufacturer and marketer of a broad ran...

    Harvard Bioscience is a global developer, manuf...

    Filing Type:    PU
    ReWalk Robotics Ltd.

    ReWalk Robotics Ltd.

    ReWalk Robotics (Nasdaq: RWLK) is an innovative medical device company. We design,...

    ReWalk Robotics (Nasdaq: RWLK) is an innovative...

    Filing Type:    PU
    Wuxi Biologics (Cayman) Inc

    Wuxi Biologics (Cayman) Inc

    WuXi Biologics (stock code: 2269.HK), a Hong Kong-listed company, is a leading glo...

    WuXi Biologics (stock code: 2269.HK), a Hong Ko...

    Filing Type:    PU
    Personalis, Inc.

    Personalis, Inc.

    Personalis, Inc. is a growing cancer genomics company transforming the development...

    Personalis, Inc. is a growing cancer genomics c...

    Filing Type:    PU
    Genobank.io Inc

    Genobank.io Inc

    Genobank is the first privacy-preserving personal DNA Kit that guarantees consumer...

    Genobank is the first privacy-preserving person...

    Amount Raised:    $156,000.00
    Fundraising Status:    EC
    Filing Type:    CF
    Morningstar, Inc.

    Morningstar, Inc.

    Morningstar, Inc. is a leading provider of independent investment research in Nort...

    Morningstar, Inc. is a leading provider of inde...

    Filing Type:    PU
    Kings Crowd LLC

    Kings Crowd LLC

    KingsCrowd was founded with the vision that everyone should have access to institu...

    KingsCrowd was founded with the vision that eve...

    Amount Raised:    $191,700.00
    Fundraising Status:    EC
    Filing Type:    CF
    Gridsum Holding Inc.

    Gridsum Holding Inc.

    Gridsum Holding Inc. is a leading provider of cloud-based big-data analytics and A...

    Gridsum Holding Inc. is a leading provider of c...

    Filing Type:    PU
    ©2026 National Investor Network. All Rights Reserved.